Lipid Nanoparticles for Gene Delivery using Microfluidic Systems
Thank you for your interest in our first webinar. Please enjoy the recording of the webinar session, where we gave a brief background of gene therapy, with a particular focus on lipid nanoparticles – the most successful non-viral gene delivery vectors.
The webinar was hosted by Dr Bowen Tian, our Expert with over 16-year research experience in nanomedicine. Bowen’s PhD research was focused on the use of liposomes and lipid nanoparticles (LNP) for targeted delivery of therapeutic molecules, including drug and gene for cancer, under the supervision of Prof. Kostas Kostarelos in the School of Pharmacy, University College London from 2007-2011. Since then, he has been applying his nanomedicine expertise in cutting-edge research ranging from protein engineering to gene and cell therapy in both academia and industry.
During the webinar we discussed:
- Gene therapy : Lipid Nanoparticle (LNP) as the most successful non-viral delivery vectors for genes towards clinical applications.
- Microfluidic technology for the production of LNP gene delivery system – key challenges and available solutions.
- Main considerations for lipid formulations for mRNA delivery.
- Future applications of LNP for gene delivery: gene delivery by inhalation, organ-specific gene delivery via systemic administration.